Enhanced Oversight and Enforcement of Non-Improving Late Adopters
• The National Partnership & Identification of Late Adopters – Since 2011, the Centers for Medicare & Medicaid Services (CMS)
has seen a reduction of 38.9 percent in long-stay nursing home residents who were receiving an antipsychotic medication. Despite
the success of the National Partnership, CMS identified approximately 1,500 facilities that had not improved their antipsychotic
medication utilization rates for long-stay nursing home residents, referred to as late adopters. In December 2017, CMS notified
these facilities of this identification.
• Enforcement for A Segment of Non-Improving Late Adopters with Multiple Citations - As of January 2019, there are 235 late
adopter nursing homes that have been cited for noncompliance with federal regulations related to unnecessary medications or
psychotropic medications two or more times since January 1, 2016, and who have not shown improvement in their long-stay antipsychotic
medication rates. If these facilities are determined not to be in substantial compliance with requirements for Chemical Restraints,
Dementia Care, or Psychotropic Medications during a survey, they will be subject to enforcement remedies for such noncompliance.
• Corporate Engagement - CMS is also looking for opportunities to engage with corporate chains that have significant numbers
of nursing homes identified as late adopters.